Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Immucell (ICCC) recorded Liabilities and Shareholders Equity of $47.96 million in Q3 2026, up 12.8% from $42.53 million a year earlier and up 2.8% from the prior quarter.

Analysis

Immucell (ICCC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Immucell reported Liabilities and Shareholders Equity of $42.53 million, down 5.7% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $45.1 million in FY2024 (+3.0%), $43.81 million in FY2023 (-2.3%), $44.86 million in FY2022 (+0.9%) and $44.47 million in FY2021 (+10.2%).
  • The Q3 2026 figure is the highest quarterly Liabilities and Shareholders Equity in data going back to Q1 2009.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 2.5%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 17.9% in Q1 2022, against a decline of 7.7% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $46.63 million (Q2 2026), $44.11 million (Q1 2026) and $42.53 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 47.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 47.96 Mn
Jun 30, 2026 46.63 Mn
Mar 31, 2026 44.11 Mn
Dec 31, 2025 42.53 Mn
Sep 30, 2025 45.73 Mn
Jun 30, 2025 42.53 Mn
Mar 31, 2025 45.62 Mn
Dec 31, 2024 45.10 Mn
Sep 30, 2024 44.45 Mn
Jun 30, 2024 41.86 Mn
Mar 31, 2024 43.05 Mn
Dec 31, 2023 43.81 Mn
Sep 30, 2023 44.55 Mn
Jun 30, 2023 44.01 Mn
Mar 31, 2023 43.12 Mn
Dec 31, 2022 44.86 Mn
Sep 30, 2022 46.40 Mn
Jun 30, 2022 45.98 Mn
Mar 31, 2022 46.70 Mn
Dec 31, 2021 44.47 Mn
API Access

Immucell Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEY